UDP-galactose-4-epimerase (EC. 5. 1. 3. 2) (abbreviated as EPase), which was discovered by Leloir (1951) , not only functions as the third enzyme participating in the metabolism of galactose (abbreviated as Gal), but also serves in the synthesis of Gal from glucose in the reversed reaction when galactose is necessary to the living body.
In 1971, Gitzelmann (1972) first discovered the newborn infant with EPase deficiency.
Since then, Gitzelmann and associates reported a total of 7 patients with EPase deficiency including 3 newborn infants discovered among those showing elevated blood levels of galactose-l-phosphate (abbreviated as Gal-1-P) which were detected through mass screening; one girl was the sister of one of the infants, and 3 women aged 60 years or more (Gitzelmann and Steinmann 1973; Mitchell et al. 1975; Gitzelmann et al. 1976 ). Conventionally, EPase activity is determined by using a considerable amount of blood and measuring the absorbance of NADH at 340 nm in the deproteinized sample. However, this procedure is not suitable for mass screening. We have devised a new mass screening method for detecting EPase deficiency in newborn infants which, like Beutler's method (Beutler and Baluda 1966), enables one to perform convenient spot test. This paper is a report on the preferred reaction system for our new method.
MATERIALS AND METHODS

Principle.
EPase converts UDP-galactose (abbreviated as UDP-Gal) to UDP-glucose which, in the presence of UDP-glucose dehydrogenase (abbreviated as UDPGDHase), reacts with NAD to form UDP-glucuronate and NADH.
The resulting NADH is fluoro metrically determined with an ultraviolet light detector.
Reagents. UDP-Gal (Sigma, Boehringer), NAD, NADH, UDPGDHase (Boehringer Time course of fluorescence intensity during incubation
As can be seen in Table 1 , it took 6-17 hr to attain a maximum fluorescence intensity.
In system I, it also took 17 hr to attain a maximum fluorescence intensity ( Table 2 ). All control systems were rated as fluorescence-negative. EPase activities in patients discovered by Paigen's, Fujimura's and Beutler's methods
Effect of buffer type on EPase activity
Our method was employed to determine EPase activity in 30 patients whose reaction had been detected by Guthrie testing of approximately 30,000 newborn infants (Table 4) . They showed abnormally high values when tested by Paigen's method; abnormally high Gal-i-P and galactose (abbreviated as Gal) values when tested by Fujimura's method; or galactosemia positive or false-positive results when tested by Beutler's method. The patients showing abnormally high Gal-i-P values were suspected to EPase deficiency, but no cases of EPase deficiency were found in the present study. However, a few patients showing lower EPase activities appeared to be heterozygotes. In Table 4 , Patient 1 gave the following laboratory findings: higher than 20 mg% by Paigen's method; 24.4 mg% Gal and 6.4 mg% Gal-1-P by Fujimura's method; and normal by Beutler's method. This patient was initially suspected of galactokinase deficiency, but the activity of EPase was found to be normal. Patients 2 and 3, who were the parents of patient 1, were suspected of cataract. It is of interest that, although their laboratory finding were approximately 0 mg% Gal and Gal-1-P by Fujimura's method and normal by Beutler's method, the activity of EPase was slightly reduced in both. Patients 24 and 25 suffering from galactosemia were under medical treatment. Their Gal-1-P and Gal values were practically zero, but their EPase activities were lower than those of the remaining patients. Of the patients showing values of higher than 20 mg%, 12-20 mg%, 8-12 m6%, 8 mg%, 6-8 mg% and 4-6 mg% by Paigen's method, the majority had normal EPase activities. However, patient 12 (8 mg% by Paigen's method; 11.9 mg% Gal-1-P and 2.5 mg% Gal by Fujimura's method), patient 16 (6-8 mg% by Paigen's; normal by Beutler's), patient 22 (4-6 mg% by Paigen's; 7.1 mg% Gal-1-P and 0. heterozygotes. We expect that our method will find wide acceptance for mass screening purposes.
